Skip to content

This clinical trial will be performed to evaluate the effect of Ayruvedic medicine Rakta Sarshapa Pralepa with Goghrit Marsha Nasya in Vataj Shirshoola which includes pain in region of forehead, between eyebrows, neck and pain aggravates at night time as well as intolerant to light.

A randomised controlled clinical study to evaluate the effect of Rakta Sarshapa Brassica juncea Pralepa and Goghrit Marsha Nasya in Vataj Shirshoola. - NO

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104536
Enrollment
52
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G442- Tension-type headache

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing minimum 3 symptoms of VatajShirshoola - Patients are having classical signs and symptoms of VatajShirshoola.-Sites of pain -Sankha, Lalata, Manya, Karna.-Intolerant to light.-Dull ache or throbbing pain (Severity of pain).-Commonly pain in the temples, between eyebrows and back of neck.-Specially, pain aggravates at night time.

Exclusion criteria

Exclusion criteria: K/C/O-Sinus headache, brain tumor, stroke, meningitis, high blood pressure (hypertension), psychosis, Pralepaand NasyaAyogyaVyakti Any pathology involving in eyes. Allergic to Sarshapa.

Design outcomes

Primary

MeasureTime frame
To identify the difference in between the treatment for the management of Vataj Shirshoola. To compare the effevtiveness of treatment over the period of time. To compare the efficacy of Rakta Sarshapa Pralepa and Goghrit Marsha Nasya.Timepoint: 5 days treatment with 3 follow ups 3rd 5th and 7th day.

Secondary

MeasureTime frame
To assess the efficacy of Goghrit Marsha Nasya with Rakta Sarshapa Pralepa. To observe the adverse effect of drug, if anyTimepoint: 5 days treatment follow ups on 3rd 5th and 7th day.

Countries

India

Contacts

Public ContactDr Neelima Sanket Amrute

PDEAs College of Ayurved and Research Centre Nigdi Pune

nilimasamrute@gmail.com7498320485

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026